XP XP Inc.

Nasdaq xpinc.com


$ 17.85 $ 0.00 (0 %)    

Wednesday, 29-Oct-2025 04:31:44 EDT
QQQ $ 634.99 $ 0.00 (0 %)
DIA $ 475.96 $ 0.00 (0 %)
SPY $ 687.85 $ 0.00 (0 %)
TLT $ 92.02 $ 0.00 (0 %)
GLD $ 369.42 $ 0.00 (0 %)
$ 17.87
$ 17.66
$ 16.94 x 160
$ 18.10 x 18
-- - --
$ 10.82 - $ 20.64
4,139,867
na
9.6M
$ 0.96
$ 0.01
TBD
na
na ($ 0.04)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ubs-maintains-buy-on-xp-lowers-price-target-to-23

UBS analyst Thiago Batista maintains XP (NASDAQ:XP) with a Buy and lowers the price target from $24 to $23.

 price-over-earnings-overview-xp
Price Over Earnings Overview: XP
10/07/2025 21:01:14

 citigroup-maintains-buy-on-xp-raises-price-target-to-23

Citigroup analyst Gustavo Schroden maintains XP (NASDAQ:XP) with a Buy and raises the price target from $22 to $23.

 stock-market-today-nasdaq-100-futures-slip-palo-alto-xp-allarity-earnings-in-focus-updated

U.S. stock futures slipped on Monday following Friday's mixed moves. Futures of major benchmark indices were lower.

 xps-earnings-a-preview
XP's Earnings: A Preview
08/15/2025 14:01:17

 ubs-maintains-buy-on-xp-raises-price-target-to-24

UBS analyst Thiago Batista maintains XP (NASDAQ:XP) with a Buy and raises the price target from $17 to $24.

 goldman-sachs-upgrades-xp-to-buy-raises-price-target-to-23

Goldman Sachs analyst Tito Labarta upgrades XP (NASDAQ:XP) from Neutral to Buy and raises the price target from $17 to $23.

 goldman-sachs-maintains-neutral-on-xp-raises-price-target-to-17

Goldman Sachs analyst Tito Labarta maintains XP (NASDAQ:XP) with a Neutral and raises the price target from $15 to $17.

 b-of-a-securities-maintains-neutral-on-xp-raises-price-target-to-19

B of A Securities analyst Mario Pierry maintains XP (NASDAQ:XP) with a Neutral and raises the price target from $16 to $19.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION